exogenous surfactant

DRUG2 trials

Sponsors

Ege University, Shahid Beheshti University of Medical Sciences

Conditions

COVID-19Respiratory Distress SyndromeSurface-Active Agents

Phase 4

Effects of Bolus Surfactant Therapy on Peripheral Perfusion Index and Tissue Carbon Monoxide

CompletedNCT01923844

Ege UniversityRespiratory Distress Syndrome

Start: 2012-03-31End: 2013-04-30Updated: 2013-08-16

Unknown Phase

Exogenous Surfactant Through Nebulizer Mask on Clinical Outcomes in Covid-19 Patients

Shahid Beheshti University of Medical SciencesCOVID-19, Respiratory Distress Syndrome, Surface-Active Agents

Start: 2021-04-20End: 2021-09-20Target: 60Updated: 2021-04-19